Revision as of 07:41, 21 April 2012 editMSBOT (talk | contribs)13,809 editsm r2.7.3) (Robot: Adding fa:متیلندیاکسیمتوکسیاتیلآمفتامین← Previous edit | Latest revision as of 20:53, 10 March 2024 edit undoInternetArchiveBot (talk | contribs)Bots, Pending changes reviewers5,386,108 edits Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.5) (Maxim Masiutin - 17955 | ||
(13 intermediate revisions by 12 users not shown) | |||
Line 1: | Line 1: | ||
{{chembox | {{chembox | ||
| Verifiedfields = changed | |||
⚫ | | verifiedrevid = |
||
| Watchedfields = changed | |||
⚫ | | verifiedrevid = 424728565 | ||
| Name=Methylenedioxymethoxyethyl{{shy}}amphetamine | |||
| ImageFile = MDMEOET.png | | ImageFile = MDMEOET.png | ||
| ImageSize = 200px | | ImageSize = 200px | ||
| |
| PIN = 1-(2''H''-1,3-Benzodioxol-5-yl)-''N''-(2-methoxyethyl)propan-2-amine | ||
| OtherNames = | | OtherNames = | ||
| |
|Section1={{Chembox Identifiers | ||
| CASNo_Ref = {{cascite|correct|??}} | |||
| CASNo = 74698-44-5 | | CASNo = 74698-44-5 | ||
| |
| UNII = YPA4B5U3U8 | ||
| PubChem = 44719584 | |||
| SMILES = C1=C2C(=CC=C1CC(C)NCCOC)OCO2}} | |||
| DTXSID = DTXSID10660371 | |||
⚫ | | |
||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | |||
| ChemSpiderID = 21106334 | |||
| SMILES = CC(Cc1ccc2c(c1)OCO2)NCCOC | |||
| InChI = 1/C13H19NO3/c1-10(14-5-6-15-2)7-11-3-4-12-13(8-11)17-9-16-12/h3-4,8,10,14H,5-7,9H2,1-2H3 | |||
| InChIKey = LOZJEWOZOKSOKA-UHFFFAOYAB | |||
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} | |||
| StdInChI = 1S/C13H19NO3/c1-10(14-5-6-15-2)7-11-3-4-12-13(8-11)17-9-16-12/h3-4,8,10,14H,5-7,9H2,1-2H3 | |||
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} | |||
| StdInChIKey = LOZJEWOZOKSOKA-UHFFFAOYSA-N}} | |||
⚫ | |Section2={{Chembox Properties | ||
| Formula = C<sub>13</sub>H<sub>19</sub>NO<sub>3</sub> | | Formula = C<sub>13</sub>H<sub>19</sub>NO<sub>3</sub> | ||
| MolarMass = 237.295 g/mol | | MolarMass = 237.295 g/mol | ||
Line 17: | Line 31: | ||
| BoilingPt = | | BoilingPt = | ||
| Solubility = }} | | Solubility = }} | ||
| |
|Section3={{Chembox Hazards | ||
| MainHazards = | | MainHazards = | ||
| FlashPt = | | FlashPt = | ||
| |
| AutoignitionPt = }} | ||
}} | }} | ||
'''MDMEOET''', or 3,4-]enedioxy-N-]]], is a lesser-known ] and a ]. It is also the N-methoxyethyl analogue of ]. MDMEOET was first synthesized by ]. In his book '']'', the minimum dosage is listed as 180 ]. MDMEOET produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMEOET. | '''MDMEOET''', or 3,4-]enedioxy-N-]]], is a lesser-known ] and a ]. It is also the N-methoxyethyl analogue of ]. MDMEOET was first synthesized by ]. In his book '']'', the minimum dosage is listed as 180 ]. MDMEOET produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMEOET. | ||
==Legality== | |||
===United Kingdom=== | |||
This substance is a Class A drug in the ].<ref>{{cite web | title = UK Misuse of Drugs act 2001 Amendment summary | url = http://isomerdesign.com/Cdsa/scheduleUK.php?schedule=1&ion=30&structure=C | accessdate = 12 March 2014 | publisher = Isomer Design | archive-date = 22 October 2017 | archive-url = https://web.archive.org/web/20171022085110/http://isomerdesign.com/Cdsa/scheduleUK.php?schedule=1&ion=30&structure=C | url-status = dead }}</ref> | |||
== See also == | == See also == | ||
Line 29: | Line 48: | ||
* ] | * ] | ||
* ] | * ] | ||
==References== | |||
{{Reflist}} | |||
== External links == | == External links == | ||
Line 35: | Line 57: | ||
{{Methylenedioxyphenethylamines}} | {{Methylenedioxyphenethylamines}} | ||
{{PiHKAL}} | |||
] | ] | ||
] | ] | ||
⚫ | {{Psychoactive-stub}} | ||
⚫ | {{Psychoactive-stub}} | ||
] |
Latest revision as of 20:53, 10 March 2024
Names | |
---|---|
Preferred IUPAC name 1-(2H-1,3-Benzodioxol-5-yl)-N-(2-methoxyethyl)propan-2-amine | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
ChemSpider | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C13H19NO3 |
Molar mass | 237.295 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). N verify (what is ?) Infobox references |
MDMEOET, or 3,4-methylenedioxy-N-methoxyethylamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N-methoxyethyl analogue of MDA. MDMEOET was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 180 mg. MDMEOET produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMEOET.
Legality
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.
See also
References
- "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.
External links
This psychoactive drug-related article is a stub. You can help Misplaced Pages by expanding it. |